R. Arellano

Predictive value of PAK6 and PSMB4 expression in patients with localized prostate cancer treated with dose-escalation radiation therapy and androgen deprivation therapy.

F. García-Vicente, M. Morente, A. Zapatero, 2014, Urologic oncology.

Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy.

A. Zapatero, C. Martín de Vidales, M. Rabadán, 2012, Urology.

Invasive bladder cancer: A single‐institution experience with bladder‐sparing approach

L. Cerezo, A. Zapatero, C. Martín de Vidales, 2000, International journal of cancer.

HIF1A expression in localized prostate cancer treated with dose escalation radiation therapy.

M. Morente, A. Zapatero, M. Adrados, 2015, Cancer biomarkers : section A of Disease markers.

Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer.

A. Zapatero, L. Pérez, J. Rogado, 2019, Urology.

Updated results of bladder-sparing trimodality approach for invasive bladder cancer.

A. Zapatero, C. Martín de Vidales, R. Arellano, 2010, Urologic oncology.

author reply.

A. Zapatero, R. Arellano, D. Büchser, 2019, Urology.